0000000000-20-009370.txt : 20210127 0000000000-20-009370.hdr.sgml : 20210127 20201005154619 ACCESSION NUMBER: 0000000000-20-009370 CONFORMED SUBMISSION TYPE: UPLOAD PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20201005 FILED FOR: COMPANY DATA: COMPANY CONFORMED NAME: Medirom Healthcare Technologies Inc. CENTRAL INDEX KEY: 0001819704 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PERSONAL SERVICES [7200] IRS NUMBER: 000000000 STATE OF INCORPORATION: M0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: UPLOAD BUSINESS ADDRESS: STREET 1: 2-3-1 DAIBA, MINATO-KU CITY: TOKYO STATE: M0 ZIP: 135-0091 BUSINESS PHONE: 81-3-6721-7364 MAIL ADDRESS: STREET 1: 2-3-1 DAIBA, MINATO-KU CITY: TOKYO STATE: M0 ZIP: 135-0091 LETTER 1 filename1.pdf begin 644 filename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end TEXT-EXTRACT 2 filename2.txt United States securities and exchange commission logo October 5, 2020 Kouji Eguchi Chief Executive Officer Medirom Healthcare Technologies Inc. 2-3-1 Daiba, Minato-ku Tokyo 135-0091, Japan Re: Medirom Healthcare Technologies Inc. Draft Registration Statement on Form F-1 Submitted on September 11, 2020 CIK 0001819704 Dear Mr. Eguchi: We have reviewed your draft registration statement and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter by providing the requested information and either submitting an amended draft registration statement or publicly filing your registration statement on EDGAR. If you do not believe our comments apply to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing the information you provide in response to these comments and your amended draft registration statement or filed registration statement, we may have additional comments. Draft Registration Statement on Form F-1 Selected Consolidated Financial Information and Operating Data Reconciliation of non-GAAP measures, page 43 1. You present a reconciliation of the non-GAAP measure Adjusted EBITDA to operating income. Please tell us your consideration of the guidance in Question 103.02 of the Non- GAAP Compliance and Disclosure Interpretations related to considering net income as the most directly comparable GAAP financial measure. Kouji Eguchi FirstName LastNameKouji EguchiInc. Medirom Healthcare Technologies Comapany October NameMedirom Healthcare Technologies Inc. 5, 2020 October Page 2 5, 2020 Page 2 FirstName LastName Management's Discussion and Analysis of Financial Condition and Results of Operations Results of Operations Comparison of the Results for the Years Ended December 31, 2019 and December 31, 2018, page 51 2. Please expand your disclosure to explain how the change in the number of customers has affected your sales per customer key performance indicator in 2019. 3. Please provide quantified discussions to separately explain the changes in your revenues from and cost of revenues associated with directly-operated salon operations, franchising activities, and other business between the reporting periods. 4. Please provide quantified explanations for the material changes in your consolidated statement of income items, such as selling, general, and administration expenses, impairment loss on long-lived assets, interest expense, gain from bargain purchase, other income, net, and income tax expense, between reporting periods. Business Company Overview, page 62 5. Please define the term "customer management system." In this regard, we note your disclosure that "[s]ince we introduced the customer management system in 2010, we have served more than 1.57 million customers and in 2019, we served an average 59,000 customers per month." 6. Please explain why "[you] believe COVID-19 has increased customer realization." In this regard, we note your disclosure that "[t]he outbreak and associated restrictions that have been implemented have had a material adverse impact on the Company s business and cash flow from operations, similar to many businesses." Relaxation Salon Segment, page 63 7. To provide additional context for investors and balance your disclosure, please further discuss the extent to which the number of salons evidences any material known trends or uncertainties. For example, it appears that the number of salons in your table on page 64 grew at a lower percentage year-over-year. Our Growth Strategy, page 72 8. Please further discuss the material assumptions and estimates underlying your belief that "the Japanese market has a capacity for approximately 1,000 salons in suitable real estate that fits the underwriting requirements for [y]our business." In this regard, we note your disclosure on page 66 that "[y]our midterm goal is to have 1,000 salons nationwide and become the number one salon network in Japan." 9. We note your disclosure throughout the registration statement that you intend to grow your business to new markets, particularly in the United States. Please expand your Kouji Eguchi FirstName LastNameKouji EguchiInc. Medirom Healthcare Technologies Comapany October NameMedirom Healthcare Technologies Inc. 5, 2020 October Page 3 5, 2020 Page 3 FirstName LastName disclosure to include a more detailed discussion of the costs involved in your proposed strategic plans, including any material commitments for capital expenditures and proposed sources of funding. In this regard, we note your disclosure that "[i]n the United States, we have developed and continue to sharpen our pipeline of operating partners in the bodywork and physical therapy industry." Our Competitive Strengths, page 74 10. We note your disclosure that "[you] own and run [y]our own job portal website, targeting prospective therapist candidates...[the] website has surpassed 11,000 pageviews shortly after launch and has already contributed over 179 suitable candidates as of June 30, 2020. To provide additional context for investors please quantify, if possible, the percentage of new employees that have been hired using your website. In this regard, we note your disclosure that "[t]his digital solution to recruiting is expected to reduce [y]our hiring cost otherwise paid to headhunters and manpower agents, by approximately JPY10,000,000 (US$92,790) in FY 2020." Regulation of Our Industry Regulations Governing Dispatched Employees for Franchisees, page 83 11. Please clarify if Medirom Human Resources Inc. has the required worker dispatch license. In this regard, we note your disclosure that MHR is required to obtain a worker dispatch license from the Ministry of Health, Labor and Welfare of Japan under the Dispatch Act. Regulations Governing Prepaid Cards, page 83 12. We note your disclosure regarding prepaid cards and the Outstanding Amount that must be paid to the Legal Affairs Bureau. If material, please consider quantifying such amount. Consolidated Statements of Income, page F-4 13. We note that you recognize revenues from services, sublease rental and other activities. Please tell us your consideration of the guidance in Rule 5-03.1 of Regulation S-X that requires separate presentation of revenues and costs associated with services, rental income, and other activities. Notes to Consolidated Financial Statements 1. Basis of Presentation and Summary of Significant Accounting Policies Revenue Recognition, page F-15 14. We note that you record rental income for operating leases on properties subleased to franchisees as franchise revenue. Please provide us with reference to the authoritative literature that supports your accounting. Kouji Eguchi Medirom Healthcare Technologies Inc. October 5, 2020 Page 4 General 15. Please disclose the basis for all your assertions about your competitive position within your industry. If you do not have appropriate independent support for a statement, please revise the language to make clear that this is your belief based upon your experience in the industry, if true. For example, please disclose the basis for your assertion that "[you have] lower employee turnover rates than [y]our competitors." You may contact Suying Li at 202-551-3335 or Donna Di Silvio at 202-551-3202 if you have questions regarding comments on the financial statements and related matters. Please contact Jennifer Lopez-Molina at 202-551-3792 or Lilyanna Peyser at 202-551-3222 with any other questions. FirstName LastNameKouji Eguchi Sincerely, Comapany NameMedirom Healthcare Technologies Inc. Division of Corporation Finance October 5, 2020 Page 4 Office of Trade & Services FirstName LastName